Christie P M Verkleij

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Endoplasmic Reticulum Stress

Top Venues

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Christie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans, Kristine A Frerichs, Wassilis S C Bruins, Carolien Duetz, Sandy Kruyswijk, S Rubina Baglio, Sheri Skerget, Rocio Montes de Oca, Sonja Zweegman, Raluca I Verona, Tuna Mutis, Niels W C J van de Donk
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Christie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans, Kristine A Frerichs, Wassilis S C Bruins, Carolien Duetz, Sandy Kruyswijk, S Rubina Baglio, Sheri Skerget, Rocio Montes de Oca, Sonja Zweegman, Raluca I Verona, Tuna Mutis, Niels W C J van de Donk
T cell characteristics impact response and resistance to T cell-redirecting bispecific antibodies in multiple myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kristine A Frerichs, Monique C Minnema, Mark-David Levin, Annemiek Broijl, Gerard M J Bos, Marie José Kersten, Tuna Mutis, Christie P M Verkleij, Inger S Nijhof, Patricia W C Maas-Bosman, Saskia K Klein, Sonja Zweegman, Pieter Sonneveld, Niels W C J van de Donk
Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma. Blood advances 5 (23) (2022)
Anne W J Martens, Joanne M Rietveld, Renate de Boer, Fleur S Peters, An Ngo, Lotte W H G van Mil, Koen de Heer, Marcel Spaargaren, Christie P M Verkleij, Niels W C J van de Donk, Homer C Adams, Eric Eldering, Carel J M van Noesel, Raluca I Verona, Arnon P Kater
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas. Cancer research communications 2 (5) (2022)
Anne W J Martens, Joanne M Rietveld, Renate de Boer, Fleur S Peters, An Ngo, Lotte W H G van Mil, Koen de Heer, Marcel Spaargaren, Christie P M Verkleij, Niels W C J van de Donk, Homer C Adams, Eric Eldering, Carel J M van Noesel, Raluca I Verona, Arnon P Kater
Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas. Cancer research communications 2 (5) (2022)
Mashhour Hosny, Christie P M Verkleij, Jort van der Schans, Kristine A Frerichs, Tuna Mutis, Sonja Zweegman, Niels W C J van de Donk
Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. Journal of clinical medicine 10 (19) (2021)
Kristine A Frerichs, Christie P M Verkleij, Meletios- Athanasios Dimopoulos, Jhon A Marin Soto, Sonja Zweegman, Mary H Young, Kathryn J Newhall, Tuna Mutis, Niels W C J van de Donk
Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients. Cancers 13 (10) (2021)
Christie P M Verkleij, Amy Jhatakia, Marloes E C Broekmans, Kristine A Frerichs, Sonja Zweegman, Tuna Mutis, Natalie A Bezman, Niels W C J van de Donk
Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies. Cancers 12 (12) (2020)